Metraipolis › archive › dc_7e7fc867f920
CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292392
- DOI
- 10.3389/fimmu.2026.1839064
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:04:12.336Z
- SHA-256 of the archived text
b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed- Stable URL of this page
https://metraipolis.com/documento/dc_7e7fc867f920
How to cite
CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392 — Europe PMC (en), https://europepmc.org/article/MED/42292392 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e7fc867f920 (Metraipolis archive dc_7e7fc867f920, sha256 b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed)
BibTeX
@misc{dc7e7fc867f920,
title = {CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292392},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e7fc867f920; sha256 b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292392. Agents can read the archived copy with the MCP tool read_document.